Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.79
-0.44 (-4.77%)
At close: Mar 11, 2026, 4:00 PM EDT
8.98
+0.19 (2.16%)
After-hours: Mar 11, 2026, 6:22 PM EDT
Kyverna Therapeutics Employees
Kyverna Therapeutics had 129 employees as of September 30, 2025. The number of employees increased by 10 or 8.40% compared to the same quarter last year.
Employees
129
Change
10
Growth
8.40%
Revenue / Employee
n/a
Profits / Employee
-$1,248,000
Market Cap
502.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 129 | 10 | 8.40% |
| Jun 30, 2025 | 129 | 17 | 15.18% |
| Mar 31, 2025 | 119 | 19 | 19.00% |
| Dec 31, 2024 | 112 | 16 | 16.67% |
| Sep 30, 2024 | 119 | 30 | 33.71% |
| Jun 30, 2024 | 112 | 23 | 25.84% |
| Mar 31, 2024 | 100 | - | - |
| Dec 31, 2023 | 96 | - | - |
| Sep 30, 2023 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Lyell Immunopharma | 300 |
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| Prothena Corporation | 163 |
| Invivyd | 100 |
| Lexeo Therapeutics | 61 |
| Fulcrum Therapeutics | 55 |
KYTX News
- 6 days ago - Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026 - GlobeNewsWire
- 8 days ago - Kyverna Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 8 days ago - Kyverna Therapeutics: The King Of The CAR-T Autoimmune Revolution - Seeking Alpha
- 15 days ago - Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors - GlobeNewsWire
- 5 weeks ago - Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer - GlobeNewsWire
- 2 months ago - Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 2 months ago - Kyverna Therapeutics: Taking The Next Step In Autoimmune Cell Therapies - Seeking Alpha